Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)
China
· Delayed Price · Currency is CNY 15.36
-0.37 (-2.35%)
Mar 9, 2026, 3:04 PM CST
SHE:002020 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 12,499 | 11,021 | 10,952 | 10,487 | 8,188 | 6,637 | Upgrade
|
| Market Cap Growth | 16.32% | 0.63% | 4.43% | 28.08% | 23.37% | -10.06% | Upgrade
|
| Enterprise Value | 12,116 | 10,330 | 9,961 | 8,947 | 6,447 | 4,871 | Upgrade
|
| Last Close Price | 15.36 | 12.46 | 12.06 | 11.33 | 8.55 | 7.21 | Upgrade
|
| PE Ratio | 17.91 | 15.48 | 17.70 | 15.84 | 13.37 | 10.16 | Upgrade
|
| Forward PE | 16.70 | 9.18 | 9.18 | 9.18 | 10.14 | 13.23 | Upgrade
|
| PS Ratio | 3.13 | 2.65 | 2.74 | 2.78 | 2.36 | 2.04 | Upgrade
|
| PB Ratio | 2.20 | 1.84 | 1.98 | 2.03 | 1.67 | 1.69 | Upgrade
|
| P/TBV Ratio | 2.54 | 2.10 | 2.30 | 2.40 | 1.88 | 1.89 | Upgrade
|
| P/FCF Ratio | 24.92 | 23.18 | 40.07 | 30.83 | - | 37.04 | Upgrade
|
| P/OCF Ratio | 17.15 | 15.18 | 13.81 | 12.26 | 21.93 | 12.93 | Upgrade
|
| PEG Ratio | - | 0.79 | 0.79 | 0.79 | 0.79 | 0.79 | Upgrade
|
| EV/Sales Ratio | 3.03 | 2.48 | 2.49 | 2.37 | 1.86 | 1.50 | Upgrade
|
| EV/EBITDA Ratio | 11.88 | 10.44 | 12.69 | 11.67 | 9.03 | 7.58 | Upgrade
|
| EV/EBIT Ratio | 17.84 | 14.46 | 17.20 | 14.58 | 11.16 | 9.38 | Upgrade
|
| EV/FCF Ratio | 24.16 | 21.72 | 36.45 | 26.30 | - | 27.18 | Upgrade
|
| Debt / Equity Ratio | 0.04 | 0.05 | 0.06 | 0.06 | 0.04 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 0.24 | 0.32 | 0.40 | 0.38 | 0.27 | 0.47 | Upgrade
|
| Debt / FCF Ratio | 0.49 | 0.67 | 1.18 | 0.87 | - | 1.68 | Upgrade
|
| Net Debt / Equity Ratio | -0.07 | -0.14 | -0.23 | -0.31 | -0.36 | -0.47 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.41 | -0.83 | -1.64 | -2.11 | -2.51 | -2.90 | Upgrade
|
| Net Debt / FCF Ratio | -0.83 | -1.74 | -4.72 | -4.76 | 53.62 | -10.40 | Upgrade
|
| Asset Turnover | 0.48 | 0.51 | 0.52 | 0.54 | 0.57 | 0.58 | Upgrade
|
| Inventory Turnover | 2.66 | 2.90 | 2.79 | 2.44 | 2.63 | 2.79 | Upgrade
|
| Quick Ratio | 0.83 | 0.96 | 1.10 | 1.37 | 1.83 | 1.68 | Upgrade
|
| Current Ratio | 1.62 | 1.36 | 1.62 | 1.81 | 2.32 | 2.02 | Upgrade
|
| Return on Equity (ROE) | 12.47% | 12.46% | 11.64% | 13.26% | 13.99% | 17.09% | Upgrade
|
| Return on Assets (ROA) | 5.13% | 5.42% | 4.72% | 5.52% | 5.91% | 5.75% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.15% | 12.92% | 13.07% | 16.40% | 19.71% | 24.78% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.20% | 11.30% | 9.80% | 11.10% | 11.30% | 12.60% | Upgrade
|
| Earnings Yield | 5.70% | 6.46% | 5.65% | 6.31% | 7.48% | 9.84% | Upgrade
|
| FCF Yield | 4.01% | 4.32% | 2.50% | 3.24% | -0.41% | 2.70% | Upgrade
|
| Dividend Yield | 2.23% | 2.81% | 2.49% | 2.65% | 3.51% | 4.05% | Upgrade
|
| Payout Ratio | 39.98% | 36.28% | 41.74% | 39.04% | 37.90% | 36.05% | Upgrade
|
| Buyback Yield / Dilution | 3.25% | 0.21% | 0.06% | -5.31% | -2.55% | 6.90% | Upgrade
|
| Total Shareholder Return | 5.48% | 3.02% | 2.54% | -2.66% | 0.96% | 10.95% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.